James L. Klein - May 2, 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Director
Signature
/s/ James Klein
Stock symbol
BSGM
Transactions as of
May 2, 2022
Transactions value $
$0
Form type
4
Date filed
5/4/2022, 06:03 PM
Previous filing
Nov 16, 2021
Next filing
Nov 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +50K $0.00 50K May 2, 2022 Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will have an exercise price equal to the arithmetic mean of the sale prices of the Company's common stock (or the closing bids, if no sales are reported), for the ten trading days immediately following the date of the grant.
F2 50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on May 2, 2022, provided Mr. Klein is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.